Label: MECLIZINE HYDROCHLORIDE tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 12, 2022

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active ingredient (in each tablet)

    Meclizine HCL 25 mg

  • PURPOSE

    Purpose

    Antiemetic

  • INDICATIONS & USAGE

    Uses

    For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

  • WARNINGS

    Warnings

    Do not use in children under 12 years of age unless directed by a doctor.

    Ask a doctor before use if you have

    • glaucoma

    • breathing problems, such as emphysema or chronic bronchitis

    • difficulty urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

    When using this product

    • drowsiness may occur

    • avoid alcoholic beverages

    • alcohol, sedatives and tranquilizers may increase drowsiness

    • use caution when driving a motor vehicle or operating machinery


    If pregnant or breast-feeding,ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Directions

    • to prevent motion sickness, take the first dose one hour before starting activity
    • not for frequent or prolonged use except on the advice of a doctor
    • do not exceed recommended dose

    Adults and children 12 years of age and older: Take 1-2 tablets once daily, or as directed by a doctor. Do not exceed 2 tablets in 24 hours.

  • STORAGE AND HANDLING

    Other information

    • store at room temperature 15˚-30˚C (59˚-86˚F)
    • protect from humidity

  • INACTIVE INGREDIENT

    Inactive ingredients: D&C yellow # 10 lake, lactose monohydrate, magnesium stearate, microcrystalline cellulose, colloidal silicon dioxide.

  • QUESTIONS

    Questions or Comments?

    Call 1-855-642-2594

  • BOXED WARNING (What is this?)

    Tamper evident:Do not use if safety seal is broken or missing

  • SPL UNCLASSIFIED SECTION

    Comapre to active ingredient in DRAMAMINE ® ALL DAY LESS DROWSY*

    *This product is not manufactured or distributed by the owner of registered trademark of DRAMAMINE ®

    MADE IN USA

    Manufactured by:

    APNAR PHARMA LLP

    East Windsor, NJ 08520

    Rev.:10/2022

  • PRINCIPAL DISPLAY PANEL

    NDC 24689-146-01

    Meclizine HCL 25 mg

    Antiemetic

    100 Tablets

    Meclizine HCl 25 mg YELLOW _label

  • INGREDIENTS AND APPEARANCE
    MECLIZINE HYDROCHLORIDE 
    meclizine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24689-146
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code AM4
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:24689-146-01100 in 1 BOTTLE; Type 0: Not a Combination Product11/21/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalM00911/21/2022
    Labeler - APNAR PHARMA LP (079568229)
    Establishment
    NameAddressID/FEIBusiness Operations
    APNAR PHARMA LLP118530917manufacture(24689-146) , analysis(24689-146) , pack(24689-146)